Hypophosphatemic Rickets

Reviews in Endocrine and Metabolic Disorders

Volumn 2, Issue 2, 2001, Pages 165-173

  DiMeglio, Linda A ^a   Econs, Michael J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromosome 12p13; Endopeptidase; Hypophosphatemia; Osteomalacia; Rickets; X chromosome

Indexed keywords

PHOSPHATE;

ANIMAL; BLOOD; HUMAN; HYPOPHOSPHATEMIA; METABOLISM; REVIEW; RICKETS;

ANIMALS; HUMANS; HYPOPHOSPHATEMIA; PHOSPHATES; RICKETS;

EID: 0035320103     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010054727323     Document Type: Article

References (85)

1. Albright F, Butler A, Bloomberg E. Rickets resistant to vitamin D therapy. Am J Dis Child 1937;54:529-547.
2. Winters R, Graham J, Williams T, McFalls V, Burnett C. A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature. Medicine 1958;37:97-142.
3. 3 metabolites. Am J Physiol 1977;233: E488.
4. Lee D, Walling M, Brautbar N. Intestinal phosphate absorption: Influence of vitamin D and non-vitamin D factors. Am J Physiol 1986;250:G369.
5. 3 on intestinal phosphate absorption in rats with a normal vitamin D supply. J Clin Invest 1977;60:639.
6. Greenberg B, Winters R, Graham J. The normal range of serum inorganic phosphorus and its utility as a discriminant in the diagnosis in congenital hypophosphatemia. J Clin Endocrinol Metab 1960;20:364-379.
7. Scriver C, Tenenhouse H. Mendelian phenotypes as "probes" of renal transport systems for amino acids and phosphate. In: Windhager E, ed. Renal Physiology, Handbook of Physiology Series (Section 8). Bethesda, MD, American Physiological Society: Oxford University Press, 1992; 1977.
8. Markowitz M, Rotkin L, Rosen J. Circadian rhythms of blood minerals in humans. Science 1981;213:672.
9. Walton R, Bijvoet O. Nomogram for the derivation of renal threshold phosphate concentration. Lancet 1975;2(7929):309-310.
10. Schurman S, Norden A, Scheinman S. X-linked recessive nephrolithiasis: presentation and diagnosis in children. J Pediatr 1998;132:859-862.
11. Hruska K, Slatopolsky E. Disorders of phosphorus, calcium, and magnesium metabolism. In: Schreir R, Gottschalk C, eds. Diseases of the Kidney. Boston: Little, Brown, and Co, 1997;2477-2526.
12. Econs M, Drezner M. Bone disease resulting from inherited disorders of renal tubule transport and vitamin D metabolism. In: Favus M, Coe F, eds. Disorders of Bone and Mineral Metabolism. New York: Raven Press Ltd, 1992;935-950.
13. Scheinman S, Guay-Woodford L, Thakker R, Warnock D. Genetic disorders of renal electrolyte transport. N Eng J Med 1999;340(15):1177-1187.
14. Davies M, Stanbury S. The rheumatic manifestations of metabolic bone disease. Clinics in Rheumatic Diseases 1981;7:595-646.
15. Whyte M, Schrank F, Armamento V. X-linked hypophosphatemia: A search for gender, race, anticipation, or parent of origin effects on disease expression in children. J Clin Endocrinol Metab 1996;81:4075.
16. Tenenhouse H, Econs M. Mendelian hypophosphatemias. In: Scriver C, Beudet A, Sly W, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill, (8th Edition), 2000.
17. Drezner M. Phosphorus Homeostasis and Related Disorders. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. Toronto: Academic Press, 1996;263-276.
18. Bradbury P, Brenton D, Stern G. Neurological involvement in X-linked hypophosphatemic rickets. J Neurol Neurosurg Psychiatry 1987;50:810-812.
19. Coleman E, Foote J. Craniostenosis with familial vitamin-D-resistant rickets. Brit Med J 1954;1:561-562.
20. Econs M, Samsa G, Monger M, Drezner M, Feussner J. X-linked hypophosphatemic rickets: A disease often unknown to affected patients. J Bone Min Res 1994;24:17-24.
21. Econs M, Feussner J, Samsa G, Effman E, Vogler J, Martinez S, Friedman NE, Quarles LD, Drezner MK. X-linked hypophosphatemic rickets without "rickets". Skeletal Radiol 1991;20:109-114.
22. Hardy D, Murphy W, Siegel B, Reid I, Whyte M. X-linked hypophosphatemia in adults: Prevalence of skeletal radiographic and scintigraphic features. Radiology 1989;171:403.
23. HYP consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 1995;11:130-136.
24. Eicher E, Southard J, Scriver C, Glorieux F. Hypophosphatemia: Mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci USA 1976;73:4667-4671.
25. Lyon M, Scriver C, Baker L, Tenenhouse H, Kronick J, Mandla S. The Gy mutation: Another cause of X-linked hypophosphatemia in mouse. Proc Natl Acad Sci USA 1986;83:4899-4903.
26. Kay G, Thakker R, Rastan S. Determination of a molecular map position for Hyp using a new interspecific backcross produced by in vitro fertilization. Genomics 1991;11:651-657.
27. Sonin N, Taggart R, Meyer M, Meyer R, Meyer Jr R. Molecular mapping of the mouse Gy mutation on chromosome X. Mouse Genome 1996;94:491-493.
28. Strom T, Francis F, Lorenz B, Boddrich A, Econs M, Lehrach H, Meitinger T. Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. Hum Mol Genet 1997;6:165-171.
29. Beck L, Soumounou Y, Martel J, Krishnamurthy G, Gauthier C, Goodyer CG, Tenenhouse HS. Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. J Clin Invest 1997;99(6):1200-1209.
30. Lorenz B, Francis F, Gempel K, Boddrich A, Josten M, Schmahl W, Schmidt J, Lehrach H, Meitinger T, Strom TM. Spermine deficiency in Gy mice caused by deletion of the spermine synthase gene. Hum Mol Genet 1998;7:541.
31. Meyer Jr R, Henley C, Meyer M, Morgan P, McDonald A, Mills C, Price DK. Partial deletion of both the spermine synthase gene and the Pex gene in the X-linked hypophosphatemic, Gyro (Gy) mouse. Genomics 1998;48:289.
32. Lobaugh B, Drezner M. Abnormal regulation of renal 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the X-linked hypophosphatemic mouse. J Clin Invest 1983;71:400-403.
33. Qiu Z, Tenenhouse H, Scriver C. Parental origin of mutant allele does not explain absence of gene dose in X-linked Hyp mice. Genet Res 1993;62:39-43.
34. Tenenhouse H, Beck L. Renal Na( + )-phosphate cotransporter gene expression in X-linked Hyp and Gy mice. Kidney Int 1996;49:1027-1032.
35. Kos C, Tihy F, Econs M, Murer H, Lemieux N, Tenenhouse H. Localization of a renal sodium-phosphate cotransporter gene to human chromosome 5q35. Genomics 1994;19:176-177.
36. Meyer Jr R, Meyer M, Gray R. Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J Bone Min Res 1989;4:493-500.
37. Nesbitt T, Coffman T, Griffiths R, Drezner M. Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. J Clin Invest 1992;89:1453-1459.
38. Morgan J, Hawley W, Chenoweth A, Retan W, Diethelm A. Renal transplantation in hypophosphatemia with vitamin D-resistant rickets. Arch Intern Med 1974;134:549-552.
39. Vautour L, Loertscher R, Blydt-Hansen T, Goodyear P, Goltzman D. Renal transplantation does not reverse the metabolic abnormalities associated with X-linked hypophosphatemic rickets (Abstract). Bone 1998;23:S181.
40. Ecarot B, Glorieux F, Desbarats M, Travers R, Labelle L. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Miner Res 1995;10:424-431.
41. Ecarot-Charrier B, Glorieux F, Travers R, Desbarats M, Bouchard F, Hinek A. Defective bone formation by transplanted Hypmouse bone cells into normal mice. Endocrinology 1988;123:768-773.
42. Lajeunesse D, Meyer Jr R, Hamel L. Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse. Kidney Int 1996;50:1531-1538
43. Francis F, Strom TM, Hennig S, Boddrich A, Lorenz B, Brandau O, Mohnike KL, Cagnoli M, Steffans C, Klages S, Borzym K, Pohl T, Oudet C, Econs MJ, Rowe PS, Reinharde R, Meitinger T, Lehrach H. Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. Genome Res 1997;7:573-585.
44. Welches W, Brosnihan K, Ferrario C. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci 1993;52:1461-1480.
45. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M. ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994;78(3):473-485.
46. Lee S, Lin M, Mele A, Cao Y, Farmar J, Russo D, et al. Proteolytic processing of big endothelin-3 by the kell blood group protein. Blood 1999;94(4):1440-1450.
47. Ikeda K, Emoto N, Raharjo SB, Nurhantari Y, Saiki K, Yokoyama M, Matsuo M. Molecular identification and characterization of novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides. J Biol Chem 1999;274(45):32469-32477.
48. Du L, Desbarats M, Viel J, Glorieux F, Cawthorn C, Ecarot B. cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 1996;36:22-28.
49. Kozak M. An analysis of vertebrate mRNA sequences: Intimations of translational control. J Cell Biol 1991;115:887-903.
50. Ruchon AF, Marcinkiewicz M, Siegfried G, Tenenhouse HS, DesGroseillers L, Crine P, Boileau G. Pex mRNA is localized in developing mouse osteoblasts and odontoblasts. J Histochem Cytochem 1998;46:459-468.
51. Grieff M, Mumm S, Waeltz P, Mazzarella R, Whyte MP, Thakker RV, Sclessinger D. Expression and cloning of the human X-linked hypophos-phatemia gene cDNA. Biochem Biophys Res Commun 1997;231(3):635-639.
52. Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R. Brief report: Inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. New Engl J Med 1994;330:1645-1649.
53. Nelson AE, Namkung HJ, Patava J, Wilkinson MR, Chang AC, Reddel RR, Robinson BG, Mason RS. Characteristics of tumor cell bioactivity in oncogenic osteomalacia. Mol Cell Endocrinol 1996;124(1-2):17-23.
54. Iviker R, Resnick SD, Skidmore RA. Hypophosphatemic vitamin-D resistant rickets, precocious puberty, and the epidermal nevus syndrome. Arch Dermatol 1997;133(12):1557-1561.
55. Econs M, Drezner M. Tumor-induced osteomalacia - unveiling a new hormone. New Engl J Med 1994;330:1679-1681.
56. Lipman ML, Panda D, Bennett HP, Henderson JE, Shane E, Shen Y, Goltzman D, Karaplis AC. Cloning of human PEX cDNA. Expression, subcellular localization, and endopeptidase activity. J Biol Chem 1998;273(22):13729-13737.
57. Blydt-Hansen T, Tenenhouse H, Goodyer P. PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia. Pediatr Nephrol 1999;13:607-611.
58. Dubois SG, Lajeunesse D. Evidence that a neutral endopeptidase-like activity of the hyp mouse osteoblasts is responsible for the elaboration of the inhibitor of phosphate uptake by renal cells (Abstract). J Bone Miner Res 1999;14(S1):S224.
59. Filisetti D, Ostermann G, von Bredow M, Strom T, Filler G, Ehrich J, Pannetier S, Gamier JM, Rowe P, Francis F, Julienne A, Hanauer A, Econs MJ, Oudet C. Non-random distribution of mutations in the PHEX gene, and under-detected missense mutations at non-conserved residues. Eur J Hum Genet 1999;7:615-619.
60. Bianchine JW, Stambler A, Harrison H. Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects: Original Article Series 1971;7:287-295.
61. Harrison H, Harrison H. Rickets and osteomalacia. In: Disorders of Calcium and Phosphate Metabolism in Childhood and Adolescence. Philadelphia: W.B. Saunders Company, 1979;230-249.
62. Econs M, McEnery P. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate wasting disorder. J Clin Endocrinol Metab 1997;82:674-681.
63. Econs M, McEnery P, Lennon F, Speer M. Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest 1997;100:2653.
64. White K, Speer M, Biber J, Murex H, Econs M. Refining the autosomal dominant hypophosphatemic rickets (ADHR) interval on chromosome 12p13 and localization of two candidate ADHR genes (Abstract). Bone 1998;23(5):S379.
65. Scriver C, MacDonald W, Reade T, Glorieux R, Nogrady B. Hypophosphatemic nonrachitic bone disease: an entity distinct from X-linked hypophosphatemia in the renal defect, bone involvement, and inheritance. Am J Med Genet 1977;1:101-117.
66. Tieder M, Modai D, Samuel R, Arie R, Halabe A, Bab I, Gabizon D, Liberman UA. Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med 1985;312:611-617.
67. Nishiyama S, Inoue F, Matsuda I. A single case of hypophosphatemic rickets with hypercalciuria. J Pediatr Gastroenterol Nutr 1986;5:826.
68. Proesmans W, Fabry G, Marchal G, Gillis P, Boullian R. Autosomal dominant hypophosphataemia with elevated serum 1,25 dihydroxyvitamin D and hypercalciuria. Pediatr Nephrol 1987;1:479-484.
69. Chen C, Carpenter T, Steg N, Baron R, Anast C. Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria. Pediatrics 1989;84:276.
70. Tieder M, Arie R, Bab I, Maor J, Liberman U. A new kindred with hereditary hypophosphatemic rickets with hypercalciuria -Implications for correct diagnosis and treatment. Nephron 1992;62:176.
71. Tieder M, Modai D, Shaked U, Samuel R, Arie R, Halabe A, Maor J, Weissgarten J, Averbukh Z, Cohen N, Edelstein S, Lieberman UA. "Idiopathic" hypercalciuria and a hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect. N Engl J Med 1987;316:125-129.
72. Gazit D, Tieder M, Liberman U, Passi-Even L, Bab I. Osteomalacia in hereditary hypophosphatemic rickets with hypercalciuria: A correlative clinical-histomorphometric study. J Clin Endocrinol Metab 1991;72:229.
73. Chong SS, Kozak CA, Liu L, Kristjansson K, Dunn ST, Bourdeau JE, Hughes MR. Cloning, genetic mapping, and expression analysis of a mouse renal sodium-dependent phosphate cotransporter. Am J Physiol 1995;268:F1038-F1045.
74. Olsen H, Cepeda M, Zhang Q, Rosen C, Vozzolo B. Human stanniocalcin: a possible hormonal regulator of mineral metabolism. Proc Natl Acad Sci USA 1996;93:1792-1796.
75. Custer M, Spindler B, Verrey F, Murer H, Biber J. Identification of a new gene product (Diphor-1) regulated by dietary phosphate. Am J Physiol 1997;273:F801-F806.
76. White K, Biber J, Murer H, Econs M. A PDZ domain-containing protein with homology to Diphor-1 maps to human chromosome 1q21. Ann Hum Genet 1998;62:287-290.
77. Norbis F, Boll M, Stange G, Markovich D, Verrey F, Biber J, Murer H. Identification of a cDNA/protein leading to an increased Pi-uptake in Xenopus laevis oocytes. J Membr Biol 1997;156:19-24.
78. White K, Econs M. Localization of piUS, a stimulator of cellular phosphate uptake to human chromosome 3p21.3. Somat Cell Mol Genet 1998;24:71-74.
79. Kaelbling M, Eddy R, Showes TB, Copeland NG, Gilbert DJ, Jenkins NA, Klinger HP, O'Hara B. Localization of the human gene allowing infection by gibbon ape leukemia virus to human chromosome region 2q11-q14 and to the homologous region on mouse chromosome 2. J Virol 1991;65(4):1743-1747.
80. Garcia J, Jones C, Miller A. Localization of the amphotropic murine leukemia virus receptor gene to the pericentromeric region of human chromosome 8. J Virol 1991;65:6316.
81. Beck L, Karaplis A, Amizuka N, Hewson A, Ozawa H, Tenenhouse H. Targeted inactivation of NPT2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 1998;95:5372-5377.
82. Wilson DM, Lee PD, Morris AH, Reiter EO, Gertner JM, Marcus R, Quarmby VE, Rosenfeld RG. Growth hormone therapy in hypophosphatemic rickets. American Journal of Diseases of Childhood 1991;145:1165.
83. Cameron F, Sochett E, Daneman A, Koch S. A trial of growth hormone therapy in well-controlled hypophosphatemic rickets. Clin Endocrinol (Oxf) 1999;50:577-582.
84. Carpenter TO, Keller M, Schwartz D, Mitnick M, Smith C, Ellison A, Carey D, Comite F, Horst R, Travers R, Glorieux FH, Gundberg CM, Poole AR, Insogna K. 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets - a clinical research study. J Clin Endocrinol Metab 1996;81:2381.
85. Hanna J, Niimi K, Chan J. X-linked hypophosphatemia. Genetic and clinical correlates. American Journal of Diseases of Childhood 1991;145:865.